The need for brand name Pharma products is also fueling the growth according to David Wilton, Regional Director, Corporate Solutions for Jones Lang LaSalle in Asia Pacific. He says “In most emerging markets, local consumers seek affordable drugs from known, trusted makers so early establishment in population-dense countries like China, India and Indonesia is vital to capture market share. Demand for drugs within these markets is increasing due to the shift in lifestyle created by the rise in personal income and purchasing power. This has resulted in a heightened awareness of traditionally Western diseases and associated treatments.”
This lends itself to the growing amount of clinical trials taking place in emerging markets. Many companies expanding to Latin America and Asia to reach new populations of potential clinical trial participants. The Partnerships in Clinical Trials conference series looks at many of these markets through their growing portfolio of global events - Partnerships in Clinical Trials, Partnerships in Clinical Trials Latin America and Partnerships in Clinical Trials Asia.
What are the benefits from a company expanding its resources and relocating parts/expanding of its business to emerging countries?
Share this article with your social network, just click below to share now!
|
|
No comments :
Post a Comment